Arecor Therapeutics Plc is a biopharmaceutical company that targets improving patient care by bringing medicines to market through the enhancement of existing therapeutic products. It engages through proprietary formulation technology platform, Arestat, which develops an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver reformulations of its partner's therapeutic products. The firm focuses on internal proprietary product development can be divided into following product classes: diabetes and specialty hospital care. The company was headquartered in Little Chesterford, the United Kingdom.